Kalbe Farma
Kalbe Farma, officially known as PT Kalbe Farma Tbk, is a leading pharmaceutical company headquartered in Indonesia. Established in 1966, Kalbe Farma has grown to become a prominent player in the healthcare industry, with a strong presence across Southeast Asia. The company focuses on various sectors, including prescription pharmaceuticals, consumer health products, and nutritional supplements. Kalbe Farma is renowned for its innovative approach to healthcare, offering a diverse range of products such as over-the-counter medications, herbal remedies, and advanced nutritional solutions. Its commitment to quality and research has positioned it as a trusted name in the market, achieving significant milestones in product development and distribution. With a robust market position, Kalbe Farma continues to enhance the well-being of communities through its comprehensive healthcare solutions.
DitchCarbon Score
How does Kalbe Farma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Kalbe Farma's score of 28 is higher than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Kalbe Farma's reported carbon emissions
In 2023, Kalbe Farma reported total carbon emissions of approximately 94,015,170 kg CO2e, comprising 18,484,770 kg CO2e from Scope 1 emissions and 75,530,400 kg CO2e from Scope 2 emissions. This represents a significant reduction from 2022, where total emissions were about 122,326,800 kg CO2e, with Scope 1 emissions at 24,392,200 kg CO2e and Scope 2 emissions at 97,934,590 kg CO2e. The company has consistently disclosed its emissions data for Scope 1 and Scope 2, but has not reported any Scope 3 emissions. Kalbe Farma has not set specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges, indicating a potential area for future commitment. Over the past few years, Kalbe Farma's emissions have shown fluctuations, with 2021 emissions at approximately 101,541,690 kg CO2e and 2020 emissions at about 77,959,250 kg CO2e. The company’s emissions data is not cascaded from any parent organisation, and all figures are reported directly from PT Kalbe Farma Tbk. Overall, while Kalbe Farma has made strides in reducing its carbon footprint, the absence of formal reduction targets suggests an opportunity for enhanced climate action and commitment in the future.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 14,233,290 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 63,725,950 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Kalbe Farma is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
